Morgan Stanley said in a report that it is expected that SINO BIOPHARM (01177.HK) +0.420 (+5.578%) Short selling $4.23M; Ratio 1.523% 's share price will rise over the next 60 days for the company will be benefited from the robust third-quarter profit, which grew 49% from a year ago and beat its forecast. The broker believed that the likelihood of such scenario reaches 70%-80%.
BASETROPHY GP (08460.HK) Expects Jan-Aug Results to Swing to Loss BASETROPHY GP (08460.HK) -0.013 (-8.280%) issued a profit warning. The group is expected to record a loss for the eight months ended 31 August 2017 as compared with a net profit for the same period of 2016, mainly due to the decrease in revenue recognised by the group and increase of listing expense
Comments
Post a Comment